SS
AVXL icon

SBI Securities’s Anavex Life Sciences AVXL Stock Holding History

SBI Securities’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.26K Sell
874
-705
-45% -$2.09K ﹤0.01% 2511
2026
Q1 		$4.85K Hold
1,579
– – ﹤0.01% 2041
2025
Q4 		$5.62K Sell
1,579
-9,295
-85% -$56.9K ﹤0.01% 1974
2025
Q3 		$96.8K Buy
10,874
+5,995
+123% +$60.8K ﹤0.01% 859
2025
Q2 		$45K Buy
4,879
+4,023
+470% +$34.3K ﹤0.01% 1095
2025
Q1 		$7.34K Hold
856
– – ﹤0.01% 1732
2024
Q4 		$9.19K Buy
+856
New +$6.58K ﹤0.01% 1683

Other funds holding AVXL

PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
SSWM
Sheets Smith Wealth Management Winston-Salem, North Carolina $1B AUM 29.77% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return
LA
LexAurum Advisors Overland Park, Kansas $866M AUM
AHL
Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
FFM
Forum Financial Management Lombard, Illinois $7.79B AUM 20.38% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

SBI Securities's AVXL Position: Q2 2026 in Review

SBI Securities reduced its Anavex Life Sciences (AVXL) stake by 45% in Q2 2026, selling an estimated $2.09K and leaving 874 shares worth $2.26K. The position accounts for ﹤0.01% of the portfolio, ranked #2511.

SBI Securities first reported a position in AVXL in Q4 2024 and has held it in 7 quarters since. The position peaked at $96.8K in Q3 2025. 29 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • SBI Securities held 874 shares of Anavex Life Sciences worth $2.26K as of Q2 2026.
  • SBI Securities sold 705 Anavex Life Sciences shares in Q2 2026, an estimated $2.09K.
  • Anavex Life Sciences made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2511 holding.
  • SBI Securities first reported a position in Anavex Life Sciences in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Anavex Life Sciences position peaked at $96.8K in Q3 2025.
  • 29 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.